A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer
Clinical trial NCT06757335 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06757335
- Sponsor
- Hinova Pharmaceuticals Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-07
- Primary completion
- 2026-01-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.